Literature DB >> 2143865

In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody.

C Ferran1, J Bluestone, J F Bach, L Chatenoud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143865

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo.

Authors:  Daniel R Clayburgh; Terrence A Barrett; Yueming Tang; Jon B Meddings; Linda J Van Eldik; D Martin Watterson; Lane L Clarke; Randall J Mrsny; Jerrold R Turner
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

Review 2.  Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH.

Authors:  Y Ilan; K Shailubhai; A Sanyal
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

Review 3.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

4.  Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.

Authors:  Pranita P Sarangi; Bumseok Kim; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

5. 

Authors:  Shimpei Kasagi; Dandan Wang; Pin Zhang; Peter Zanvit; Hua Chen; Dunfang Zhang; Jia Li; Li Che; Takashi Maruyama; Hiroko Nakatsukasa; Ruiqing Wu; Wenwen Jin; Lingyun Sun; WanJun Chen
Journal:  EBioMedicine       Date:  2019-05-13       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.